The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neuroscience Antibodies and Assays Market Research Report 2024

Global Neuroscience Antibodies and Assays Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1714649

No of Pages : 87

Ask Your Query

Synopsis

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

The global Neuroscience Antibodies and Assays market was valued at US$ 2415.4 million in 2023 and is anticipated to reach US$ 3691.5 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

North American market for Neuroscience Antibodies and Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Neuroscience Antibodies and Assays is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Neuroscience Antibodies and Assays in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Neuroscience Antibodies and Assays include Thermo Fisher, Abcam, Bio-Rad, Merck, Cell Signaling Technology, Genscript, Rockland Immunochemicals, BioLegend and Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays.

Report Scope

The Neuroscience Antibodies and Assays market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuroscience Antibodies and Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neuroscience Antibodies and Assays companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Thermo Fisher
  • Abcam
  • Bio-Rad
  • Merck
  • Cell Signaling Technology
  • Genscript
  • Rockland Immunochemicals
  • BioLegend
  • Santa Cruz Biotechnology
  • Roche
  • Siemens

Segment by Type

  • Consumables
  • Instruments

Segment by Application

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2019-2030)
2.2 Neuroscience Antibodies and Assays Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2019-2024)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2025-2030)
2.3 Neuroscience Antibodies and Assays Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Industry Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2019-2024)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2019-2024)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2023
3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service
3.7 Date of Enter into Neuroscience Antibodies and Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2019-2024)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2025-2030)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2019-2024)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2019-2030)
6.2 North America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2019-2024)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2019-2030)
7.2 Europe Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2019-2024)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2019-2030)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2019-2024)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2019-2030)
9.2 Latin America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2019-2024)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2019-2030)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2019-2024)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Detail
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.2.5 Abcam Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Detail
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.5.5 Cell Signaling Technology Recent Development
11.6 Genscript
11.6.1 Genscript Company Detail
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.6.5 Genscript Recent Development
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Detail
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.7.5 Rockland Immunochemicals Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Detail
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.8.5 BioLegend Recent Development
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Detail
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.9.5 Santa Cruz Biotechnology Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.10.5 Roche Recent Development
11.11 Siemens
11.11.1 Siemens Company Detail
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2019-2024)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock